Leif Niclas Fredrik Löwgren
Direktor/Vorstandsmitglied bei Omnivation AB
Aktive Positionen von Leif Niclas Fredrik Löwgren
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| Omnivation AB | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Leif Niclas Fredrik Löwgren
Ehemalige bekannte Positionen von Leif Niclas Fredrik Löwgren
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| COPPERSTONE RESOURCES AB | Direktor/Vorstandsmitglied | - | 14.05.2019 |
| NEXTCELL PHARMA AB | Direktor/Vorstandsmitglied | 01.01.2017 | - |
| QUIAPEG PHARMACEUTICALS HOLDING AB | Direktor/Vorstandsmitglied | 01.01.2017 | - |
QuiaPEG Pharmaceuticals AB
 QuiaPEG Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology QuiaPEG Pharmaceuticals AB operates as biotech company developing biopharmaceuticals based on a proprietary PEGylation technology platform. The firm’s technology is applicable on proteins, peptides, and small molecules. It develops novel long-acting biopharmaceuticals for the treatment of metabolic disorders. The company was founded by Hans Marcus Bosson in 2012 and is headquartered in Solna, Sweden. | Direktor/Vorstandsmitglied | - | - |
Ausbildung von Leif Niclas Fredrik Löwgren
| University of Stockholm | Masters Business Admin |
Statistik
International
| Schweden | 7 |
Operativ
| Director/Board Member | 5 |
| Masters Business Admin | 1 |
Sektoral
| Health Technology | 4 |
| Non-Energy Minerals | 2 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| COPPERSTONE RESOURCES AB | Non-Energy Minerals |
| NEXTCELL PHARMA AB | Health Technology |
| QUIAPEG PHARMACEUTICALS HOLDING AB | Health Technology |
| Private Unternehmen | 2 |
|---|---|
QuiaPEG Pharmaceuticals AB
QuiaPEG Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology QuiaPEG Pharmaceuticals AB operates as biotech company developing biopharmaceuticals based on a proprietary PEGylation technology platform. The firm’s technology is applicable on proteins, peptides, and small molecules. It develops novel long-acting biopharmaceuticals for the treatment of metabolic disorders. The company was founded by Hans Marcus Bosson in 2012 and is headquartered in Solna, Sweden. | Health Technology |
| Omnivation AB |
